ARDT - NYSE

Ardent Health Partners, LLC

ARDT·NYSE

$7.83

-16%

HealthcareMedical - Care Facilities

Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.12B

EPS0.9600

P/E Ratio8.16

Earnings Date08/04/2026

5.29B

Assets

3Y+9.0%

5Y+123.0%

10Y+387.0%

3.61B

Total Liabilities

3Y-5.0%

5Y+123.0%

10Y+423.0%

1.68B

Total Equity

11%

3Y+60.0%

5Y+122.0%

10Y+325.0%

Ardent Health Partners, LLC Funding & Solvency Profile

ARDT · NYSE

Current Assets

Cash & Cash Equivalents709.60M

Net Receivables686.10M

Inventory118.59M

Other Current Assets544.53M

Total Current Assets2 B

Non-Current Assets

Property, Plant & Equipment2.14B

Goodwill & Intangible Assets968.79M

Long-Term Investments0.00

Other Non-Current Assets111.69M

Total Non-Current Assets2 B

Total Assets

5.29B

Financial Health Analysis

Current Ratio

1.97x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

2.14x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

1 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

39% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Ardent Health Partners, LLC Balance Sheet

ARDT • NYSE

Ardent Health Partners, LLC Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2018	Dec 2017	Dec 2016
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	709.6M	556.8M	437.6M	456.1M	59.7M	72M	92.6M
Cash & Short-Term Investments	709.6M	556.8M	437.6M	456.1M	59.7M	72M	92.6M
Net Receivables	686.1M	743M	785.8M	612M	529.1M	453.8M	261M
Accounts Receivables	686.1M	743M	775.5M	603.4M	529.1M	453.8M	261M
Other Receivables	0.0	0.0	10.3M	8.6M	0.0	0.0	0.0
Inventory	118.6M	115.1M	105.5M	107.2M	84.8M	84.2M	47.1M
Prepaids	0.0	113.7M	77.3M	69M	86.3M	59.6M	39.3M
Other Current Assets	544.5M	304.1M	212M	165M	100.6M	66.8M	31.1M
Total Current Assets	2.1B	1.8B	1.6B	1.4B	860.4M	736.4M	471.1M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	2.1B	2B	2B	2B	839.9M	591.6M	256.5M
Goodwill	879.5M	852.1M	844.7M	844.7M	822M	818.2M	244.5M
Intangible Assets	89.3M	76.9M	76.9M	76.9M	77.8M	78.3M	71.8M
Goodwill & Intangible Assets	968.8M	929M	921.6M	921.6M	899.9M	896.4M	316.3M
Long-Term Investments	0.0	11.5M	17.8M	29.4M	0.0	0.0	0.0
Tax Assets	6.9M	12.3M	403.7M	415.5M	96M	87.3M	3.7M
Other Non-Current Assets	111.7M	131.5M	129.3M	94M	50.1M	62.8M	37.8M
Total Non-Current Assets	3.2B	3.1B	3.5B	3.5B	1.9B	1.6B	614.2M
Total Assets	5.3B	5B	5.1B	4.9B	2.7B	2.4B	1.1B
LIABILITIES
CURRENT LIABILITIES
Total Payables	457.9M	457.1M	492.6M	338.1M	230.4M	226.5M	131.9M
Accounts Payable	457.9M	401.2M	474.5M	320.8M	230.4M	226.5M	131.9M
Other Payables	0.0	55.8M	18M	17.3M	0.0	0.0	0.0
Accrued Expenses	0.0	388.1M	267.7M	244.2M	194.8M	207.3M	148.6M
Short Term Debt	23.4M	9.2M	61M	58.4M	9M	16.9M	7.7M
Capital Lease Obligations (Current)	0.0	46.4M	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	15.2M	18M	17.3M	14.8M	8.8M	7.1M
Other Current Liabilities	565.2M	44.7M	172.8M	167.8M	190.7M	56.7M	40M
Total Current Liabilities	1B	945.4M	994.1M	808.6M	624.8M	507.3M	328.1M
NON-CURRENT LIABILITIES
Long Term Debt	1.1B	1.1B	1.2B	1.2B	1.3B	935.8M	232.7M
Deferred Tax Liabilities (Non-Current)	0.0	0.0	371.2M	381M	0.0	0.0	0.0
Other Non-Current Liabilities	317.7M	261.7M	319.6M	290M	157.7M	171.1M	128.5M
Total Non-Current Liabilities	2.6B	2.5B	3B	3B	1.4B	1.1B	361.2M
Capital Lease Obligations	1.2B	1.2B	1.2B	1.2B	0.0	0.0	0.0
Total Liabilities	3.6B	3.4B	4B	3.8B	2B	1.6B	689.4M
SHAREHOLDERS' EQUITY
Common Stock	1.4M	1.4M	496.9M	511M	504.7M	401.9M	255M
Additional Paid-In Capital	0.0	754.4M	0.0	0.0	0.0	0.0	0.0
Retained Earnings	501.6M	365.8M	155.5M	101.5M	-167.2M	-24.1M	11.5M
Accumulated Other Comprehensive Income/Loss	-3.6M	9.7M	18.6M	26.5M	-5.9M	0.0	0.0
Other Total Stockholders' Equity	1.2B	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	1.7B	1.1B	670.9M	639.1M	331.6M	377.7M	266.5M
Total Equity	1.7B	1.5B	1.1B	1.1B	711.8M	760.3M	396M
Minority Interest	-1.3M	391M	411.4M	411.3M	380.2M	382.6M	129.5M
SUMMARY
Total Liabilities & Equity	5.3B	5B	5.1B	4.9B	2.7B	2.4B	1.1B
Total Investments	0.0	11.5M	17.8M	29.4M	77.8M	78.3M	71.8M
Total Debt	2.3B	2.3B	2.4B	2.4B	1.3B	952.7M	240.4M
Net Debt	1.6B	1.7B	2B	1.9B	1.2B	880.7M	147.8M
Shares Outstanding	143,106,447	143,106,447	143,106,447	143,106,447	143,106,447	143,106,447	143,106,447

SEC Filings

ARDT - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 02, 2026	June 02, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 26, 2026	May 20, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 06, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 08, 2026	May 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 27, 2026	March 24, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 16, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 04, 2026	March 04, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 18, 2025	November 17, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 14, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 36 filings

Related Guides

Blog Categories

Continue your ARDT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.